Ventavis
Links shared publicly online about this topic
Increased strength formulation of Ventavis launched - MPR
empr.com — “Actelion Pharmaceuticals has launched an increased strength formulation of Ventavis (iloprost inhalation solution), an inhaled prostacyclin analogue, for the treatment of pulmonary arterial hypertension (WHO Group I) in patients with New York Heart Association (NYHA) Class III or IV symptoms.” View full resource at empr.com
Most Recently Shared on September 2, 2009 at 2:22 pm By:
MPR News: Increased strength formulation of Ventavis launched: Actelion Pharmaceuticals has launched an.. http://bit.ly/15RRLU
Actelion launches new 20 mcg/mL Ventavis formulation
news-medical.net — “Actelion Pharmaceuticals US, Inc., today announced the first commercial sales of a new 20 microgram per milliliter (mcg/mL) formulation of Ventavis(R), for the treatment of New York Heart Association Class III and IV pulmonary arterial hypertension (PAH). This increased strength formulation delivers the same dose of Ventavis in half the volume, which is expected to reduce inhalation time and further support patient compliance.” View full resource at news-medical.net
Most Recently Shared on September 2, 2009 at 7:17 pm By:
HIV/AIDS News: Actelion launches new 20 mcg/mL Ventavis formulation: Actelion Pharmaceuticals US, .. http://bit.ly/bDz3j
Drug may prevent lung cancer, study finds | Reuters
reuters.com — “WASHINGTON (Reuters) - A drug approved to treat a range of conditions may also work to prevent lung cancer in people who have given up smoking, U.S. researchers reported on Tuesday. The drug, called iloprost,” View full resource at reuters.com
Most Recently Shared on May 19, 2010 at 2:00 am By:
Hisham Rana, MD Doctor and Physician
Study: Inhaled drug Ventavis (iloprost) may also prevent lung #cancer in smokers http://bit.ly/9ofLGW - The key is "may." #health
index -
www1.actelion.com — “Actelion is a global, independent biopharmaceutical company discovering, developing and marketing innovative drugs for high unmet medical needs. Find here the latest news & events.” View full resource at www1.actelion.com
Most Recently Shared on August 13, 2009 at 7:04 pm By:
Dr. Warren Rosenblum Doctor, Internist, Cardiologist, and Physician
Higher dose inhaled ventavis FDA approved to decrease inhalation times and improve compliance in pts with PAH : http://tinyurl.com/mvs2gq
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
News-Medical.Net
Stay up to date with the latest HIV/AIDS news and research via News-Medical.Net
-
Hisham Rana, MD
I tweet mostly about medicine, politics, and tech. Please see the link for a disclaimer and other policies.
Advertisement
